FDA - Food and Drug Administration

07/17/2026 | Press release | Distributed by Public on 07/17/2026 09:05

July 17, 2026 - FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol

FDA - Food and Drug Administration published this content on July 17, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 17, 2026 at 15:05 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]